LOKELMA Trademark

Trademark Overview

On Wednesday, April 2, 2014, a trademark application was filed for LOKELMA with the United States Patent and Trademark Office. The USPTO has given the LOKELMA trademark a serial number of 86240215. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 23, 2017. This trademark is owned by ZS PHARMA, INC.. The LOKELMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of hyperkalemia
lokelma

General Information

Serial Number86240215
Word MarkLOKELMA
Filing DateWednesday, April 2, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 23, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 22, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of hyperkalemia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 15, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZS PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94403
Party NameZS PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCoppell, TX 75019

Trademark Events

Event DateEvent Description
Monday, October 23, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 23, 2017ABANDONMENT - NO USE STATEMENT FILED
Friday, March 3, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 2, 2017EXTENSION 5 GRANTED
Thursday, February 23, 2017EXTENSION 5 FILED
Thursday, February 23, 2017TEAS EXTENSION RECEIVED
Thursday, October 13, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 13, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 1, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 31, 2016EXTENSION 4 GRANTED
Thursday, August 18, 2016EXTENSION 4 FILED
Thursday, August 18, 2016TEAS EXTENSION RECEIVED
Tuesday, March 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 14, 2016EXTENSION 3 GRANTED
Tuesday, March 1, 2016EXTENSION 3 FILED
Tuesday, March 1, 2016TEAS EXTENSION RECEIVED
Thursday, December 17, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 17, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 27, 2015EXTENSION 2 GRANTED
Wednesday, September 16, 2015EXTENSION 2 FILED
Friday, September 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 16, 2015TEAS EXTENSION RECEIVED
Wednesday, March 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 16, 2015EXTENSION 1 GRANTED
Monday, March 16, 2015EXTENSION 1 FILED
Monday, March 16, 2015TEAS EXTENSION RECEIVED
Friday, January 2, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 16, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 22, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 22, 2014PUBLISHED FOR OPPOSITION
Wednesday, July 2, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 16, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 12, 2014ASSIGNED TO EXAMINER
Tuesday, April 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, April 5, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

lokelma hyperkalemia treatment preparations pharmaceutical